Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus - Concepedia

Concepedia

Publication | Closed Access

Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus

55

Citations

18

References

2024

Year

Surender Khurana, Lisa R. King, Jody Manischewitz, Olivia Posadas, Ashish Mishra, Dongxiao Liu, John H. Beigel, Rino Rappuoli, John S. Tsang, Hana Golding

Nature Medicine

VaccinationCross-protectionVaccine DevelopmentMedicineVaccine TargetImmunologyVirologyInfluenza VaccineVaccine DesignInfluenza VirusH5n1 VaccinesCross-neutralizing AntibodiesInfluenza Vaccines

References

	Year	Citations

Page 1

Page 1